GLP-1 clinical trials enrolling now, US
55 clinical trials enrolling across 33 conditions, 26 sponsors, and 46states. Find a clinical trial that's enrolling near you. Synced quarterly from ClinicalTrials.gov.
55 clinical trials33 conditions26 sponsors46 US statesLast synced 2026-05-28
Not sure which clinical trial fits you? Take the 7-question matching quiz and we will surface the 3-5 clinical trials with the best fit on your conditions, location, and current treatment.
Take the quiz →55 of 55 clinical trials match
- A study testing whether a new weekly shot from Lilly, retatrutide, can improve fatty liver disease.Enrolling
- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH), BMI 25+.
- What you take
- retatrutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 6.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a study medicine from Novo Nordisk, cagrilintide, can help with weight.Enrolling
- Who can join
- Children and teens 8 to 18, are overweight.
- What you take
- cagrilintide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 7.7 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have obesity who also have ongoing low back pain, BMI 27+.
- What you take
- retatrutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.3 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH), BMI 25+.
- What you take
- survodutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 4.6 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
- What you take
- survodutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 7.3 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can lower blood pressure.Enrolling
- Who can join
- Adults 18+, have high blood pressure.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.4 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a study medicine from Novo Nordisk, cagrisema, can help with weight.Not yet recruiting
- Who can join
- Adults 18+, are overweight, BMI 27+.
- What you take
- cagrisema, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.6 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a study medicine from Novo Nordisk, cagrisema, can help with weight.Not yet recruiting
- Who can join
- Adults 18+, have obesity, BMI 35+.
- What you take
- cagrisema, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.9 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have osteoarthritis (joint pain), BMI 27+.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.7 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have peripheral artery disease (poor blood flow in the legs), BMI 23+.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.7 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can lower blood pressure.Enrolling
- Who can join
- Adults 18+, have high blood pressure.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.4 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Lilly, orforglipron, can lower blood pressure.Enrolling
- Who can join
- Adults 18+, have high blood pressure, BMI 25+.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.4 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a study medicine from Novo Nordisk, cagrisema, can lower blood sugar and help with weight.Not yet recruiting
- Who can join
- Children and teens 10 to 18, have type 2 diabetes.
- What you take
- cagrisema, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 3.6 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have obesity, BMI 27+.
- What you take
- retatrutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can reduce bladder leaks.Enrolling
- Who can join
- Adults 18+, women only, have stress urinary incontinence (bladder leaks), BMI 27+.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.5 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 75, have alcohol-related liver disease, BMI 25+.
- What you take
- pemvidutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.2 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot from Lilly, tirzepatide, can calm gut inflammation.Enrolling
- Who can join
- Adults 18 to 70, have ulcerative colitis, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether an investigational medicine (KAI-9531) from Kailera can help with weight.Enrolling
- Who can join
- Adults 18+, have obesity, BMI 35+.
- What you take
- KAI-9531, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.3 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a new weekly shot from Lilly, tirzepatide, can calm gut inflammation.Enrolling
- Who can join
- Adults 18 to 70, have Crohn's disease, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.9 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Children and teens 6 to 17, have obesity.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.3 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a study medicine from Novo Nordisk, cagrisema, can lower blood sugar and help with weight.Not yet recruiting
- Who can join
- Adults 18 to 64, have type 2 diabetes, BMI 25+.
- What you take
- cagrisema, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 14 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Children and teens 12 to 17, have obesity.
- What you take
- orforglipron, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 6.2 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 4.3 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes, BMI 27+.
- What you take
- LY3457263, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have psoriasis, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 3.2 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have psoriatic arthritis, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.7 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 18 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Children and teens 12 to 17, have obesity.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 6.5 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot from Gan and Lee Pharmaceuticals, USA, tirzepatide, can help with weight.Not yet recruiting
- Who can join
- Adults 18 to 75, have obesity or are overweight, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 16 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Novo Nordisk, semaglutide, can protect the kidneys.Enrolling
- Who can join
- Adults 18+, have chronic kidney disease, BMI 27+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Verdiva Bio Dev Limited, ecnoglutide, can help with weight.Not yet recruiting
- Who can join
- Adults 18 to 80, have obesity, BMI 27+.
- What you take
- ecnoglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 7 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 70, have type 2 diabetes, BMI 25+.
- What you take
- icovamenib 100 mg, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 15 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 40 to 80, have type 2 diabetes.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 6.5 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 65, have nausea and vomiting, BMI 25+.
- What you take
- Tradipitant, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 9 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Eccogene, semaglutide, can help with weight.Not yet recruiting
- Who can join
- Adults 18 to 75, have obesity, BMI 30+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 8 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help with weight.Not yet recruiting
- Who can join
- Adults 18+, have obesity.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.7 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 65 to 100, have obesity or are overweight, BMI 35+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a new weekly shot from Biomed Industries, tirzepatide, can help with weight.Not yet recruiting
- Who can join
- Adults 19 to 80, have obesity or are overweight, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 16 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a study medicine from Novo Nordisk, cagrilintide, can help with weight.Not yet recruiting
- Who can join
- Adults 18+, have obesity, BMI 30+.
- What you take
- cagrilintide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 18 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a study medicine from Novo Nordisk, cagrisema, can help with weight.Enrolling
- Who can join
- Adults 18 to 65, have obesity, BMI 30+.
- What you take
- cagrisema, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.1 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 65, have obesity or are overweight, BMI 27+.
- What you take
- olatorepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 9 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from 4Moving Biotech, liraglutide, can ease joint pain.Enrolling
- Who can join
- Adults 40 to 80, have knee osteoarthritis (joint pain), BMI 18.5+.
- What you take
- liraglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 15 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 75, have type 2 diabetes.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 4.6 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have opioid use disorder, BMI 23+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity or are overweight, BMI 30+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 3.2 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 49, have type 1 diabetes, BMI 20+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 4.5 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- Who can join
- Ages 12 to 35, women only, have polycystic ovary syndrome (PCOS), BMI 27+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 4.6 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from University of Colorado, Denver, semaglutide, can help with weight.Not yet recruiting
- Who can join
- Ages 12 to 45, have obesity, BMI 35+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 4.9 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from VA Office of Research and Development, semaglutide, can help people drink less.Not yet recruiting
- Who can join
- Adults 18 to 80, have alcohol use disorder, BMI 21+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Emory University, semaglutide, can lower blood sugar and help with weight.Not yet recruiting
- Who can join
- Adults 65+, women only, have type 2 diabetes, BMI 27+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.6 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a new weekly shot from University of Virginia, tirzepatide, can help with weight.Not yet recruiting
- Who can join
- Adults 30 to 65, have obesity or are overweight, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 10 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Children's Hospital Los Angeles, semaglutide, can help with weight.Not yet recruiting
- Who can join
- Children and teens 12 to 18, have obesity, BMI 35+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 7.4 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have hormone-receptor-positive breast cancer, BMI 27+.
- What you take
- tirzepatide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 2.9 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →- A study testing whether metformin from AgelessRx, a long-used diabetes pill, affects healthy aging.Enrolling
- Who can join
- Adults 40 to 85, are joining a healthy-aging study, BMI 22+.
- What you take
- Metformin, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The study runs about 8 months.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18 to 75, have opioid use disorder, BMI 18+.
- What you take
- semaglutide, given as part of the study at no cost to you. Some participants may receive a placebo (an inactive version) instead, decided at random.
- How long
- The full study runs about 1.8 years; your own time in it is usually shorter.
- What you get
- The study medication and study-related care at no cost. Compensation varies by study site; many cover travel and provide the study medication at no cost. The trial coordinator will explain what that site offers before you join.
Study details
View on ClinicalTrials.gov →
How this directory works
The data comes from ClinicalTrials.gov, the US federal registry for clinical research. We pull active and pre-active GLP-1 trials (semaglutide, tirzepatide, liraglutide, retatrutide, survodutide, orforglipron, cagrisema and related molecules) plus studies of GLP-1 effects on conditions like obesity, type 2 diabetes, MASH, sleep apnea, CKD, and cardiovascular disease.
We sync the data quarterly. To verify a trial is still recruiting before you contact a site, click the ClinicalTrials.gov link on the trial page. That registry is the official source of truth.
How to enroll in a clinical trial
- Find a clinical trial below or take the matching quiz. Read the eligibility criteria. The key inclusion and exclusion items are the ones the trial coordinator will check first.
- Find a site location near you. We list every US site with city, state, and contact information when the sponsor publishes it.
- Contact the site directly using the phone or email on the trial page. Tell them you read about the trial on GLP Chart and you want to be screened.
- Screening typically involves a phone call, a clinic visit, and sometimes blood work. Most trials cover the cost of screening and trial-related medical care. Some sites compensate participants for their time; the trial coordinator explains what each site offers.
- If you do not qualify for the trial you contacted, ask the site coordinator about other trials they run. Many sites run multiple GLP-1 studies at once and can route you to a better fit.
A few legal notes
GLP Chart is not affiliated with any of the sponsors or sites listed. We do not enroll patients in trials. We do not receive payment for any individual enrollment as of the date of this directory. Future commercial relationships with clinical research organizations may exist; if so they will be disclosed here and in the affiliate disclosure.
Participating in a clinical trial is a serious medical decision. Talk to your existing healthcare provider before enrolling. Trial coordinators are required by federal regulation to walk you through informed consent before you join.
Why you can trust GLP ChartSame scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each program's public-facing page weekly.